Ongoing trials in low-grade lymphoma
There are many therapies available for the management of low-grade lymphoma. With follicular lymphoma, for example, combination of chemotherapy and rituximab (immuno-chemo - therapy) and consecutive maintenance therapy for 2 years is the current standard of care. To date, the most widely used regime...
Main Author: | Alexander Burchardt |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-10-01
|
Series: | Hematology Reports |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/hr/article/view/3872 |
Similar Items
-
Resolution of granuloma annulare following treatment with bendamustine and rituximab in a patient with follicular lymphoma: A serendipitous finding
by: B K Shah, et al.
Published: (2014-01-01) -
Bendamustine in the treatment of B-cell non-Hodgkin lymphoma
by: L G Babicheva, et al.
Published: (2018-12-01) -
A case report of nodal marginal zone lymphoma: Diagnosis and management
by: Dilip Sandipan Nikam
Published: (2017-01-01) -
Encephalopathy after Bendamustine Treatment: A Rare Side Effect?
by: Carolina Amado, et al.
Published: (2020-11-01) -
Herpetic esophagitis following bendamustine-containing regimen
by: Yamane H, et al.
Published: (2016-06-01)